Medical News Summary: New breast cancer drug more successful than tamoxifen in postmenopausal women
About: New breast cancer drug more successful than tamoxifen in postmenopausal women
Date: 8 December 2004
Source: Reuters - Health
Author: Maggie Fox
Medical News Summary (summary of medical news story as reported by Reuters - Health): Researchers claim that the new breast cancer drugs, aromatase inhibitors (Arimidex), were more effective than the tradition tamoxifen at prevent a cancer reoccurrence or spread. Aromatase inhibitors also claim to have fewer side effects. Tamoxifen has fewer side effects than chemotherapy but can increase the risk of endometrial cancer, stroke, vaginal bleeding and bloating. Experts however, claim that the new drugs were effective in only about half of women. It can only be used in post menopausal women or if the cancer isn’t estrogen receptor positive as aromatase inhibitors operate by reducing estrogen levels.
URL: http://www.reuters.com/newsArticle.jhtml?type=healthNews&storyID=7031581
Related Disease Topics: Cancer, Breast cancer, Menopause, Endometrial cancer, Stroke, Vaginal bleeding, Bloating
Related Medical News Channels: This medical news summary article refers to the following medical channel categories:
- Side effects
- Side effects and cancer
- Side effects and breast cancer
- Side effects and endometrial cancer
- Side effects and stroke
- Side effects and vaginal bleeding
- Side effects and bloating
- research and cancer
- Research
- research and breast cancer
- Medication
- medication and cancer
- medication and breast cancer
- medication and endometrial cancer
- medication and stroke
- medication and vaginal bleeding
- medication and bloating
- Cause of and endometrial cancer
- Cause of and stroke
- Cause of and vaginal bleeding
- Cause of and bloating
Medical Tools & Articles:
Next articles:
Medical Articles: